Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)

122.96 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3
Open 122.96
Bid (Size) 118.50 (1)
Ask (Size) 134.00 (1)
Prev. Close 122.96
Today's Range 122.96 - 122.96
52wk Range 84.23 - 157.98
Shares Outstanding 99,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target
Neurocrine stock gains as Q1 EPS beats estimates; Ingrezza sales climb 8% YoY with record new patients and strong analyst price target hikes. 
Via Benzinga
Neurocrine Biosciences Surges On 'Surprising' Momentum For Its Newest Drug
The company reported a strong start for its newest drug, Crenessity, which treats a hormonal disorder involving the adrenal glands. 
Via Investor's Business Daily

Performance

YTD
-10.8%
-10.8%
1 Month
+22.1%
+22.1%
3 Month
+7.9%
+7.9%
6 Month
+3.2%
+3.2%
1 Year
-13.2%
-13.2%

More News

Read More
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
What 19 Analyst Ratings Have To Say About Neurocrine Biosciences
Via Benzinga
Earnings Scheduled For May 5, 2025
Via Benzinga
Assessing Neurocrine Biosciences: Insights From 15 Financial Analysts
Via Benzinga
Why Neurocrine Biosciences Stock Sank Today
Via The Motley Fool
Neurocrine Biosciences Stock Surges After-Hours On Upbeat Q1, Reaffirmed Ingrezza Outlook — Retail Buzz Soars
Via Stocktwits
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Top movers in Monday's after hours session
Via Chartmill
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is not too expensive for the growth it is showing.
Via Chartmill
What to Expect from Neurocrine Biosciences's Earnings
Via Benzinga
Neurocrine Biosciences Inc (NASDAQ:NBIX): A Strong Affordable Growth Stock
Via Chartmill
In The Holiday Shortened Easter Week, These Large-Cap Stock Were Top Performers (Apr 14-Apr 18): Are These In Your Portfolio?
Via Benzinga
Neurocrine Biosciences' Positive Crenessity Physician Survey Turns This Analyst Bullish
Via Benzinga
What 16 Analyst Ratings Have To Say About Neurocrine Biosciences
Via Benzinga
This Triumph Group Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Via Benzinga
Looking for growth without the hefty price tag? Consider NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX).
Via Chartmill
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is an undervalued gem with solid fundamentals.
Via Chartmill
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX)—A High-Growth Stock Gearing Up for Its Next Upward Move.
Via Chartmill
Neurocrine Biosciences: A Smart Biotech Bet With Blockbuster Potential
Via The Motley Fool
Deep Dive Into Neurocrine Biosciences Stock: Analyst Perspectives (14 Ratings)
Via Benzinga
Despite its growth, NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) remains within the realm of affordability.
Via Chartmill
NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via Chartmill
NASDAQ:NBIX is showing decent growth, but is still valued reasonably.
Via Chartmill

Frequently Asked Questions

Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?
Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?
Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?
The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market
What is the current price of Neurocrine Biosciences, Inc. - Common Stock?
The current price of Neurocrine Biosciences, Inc. - Common Stock is 122.96
When was Neurocrine Biosciences, Inc. - Common Stock last traded?
The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 05/20/25 04:00 PM ET
What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?
The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 12.17B
How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?
Neurocrine Biosciences, Inc. - Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.